Improving quality, safety and feasibility of cell and gene therapies in Canada through optimal manufacturing practices.
Follow @CellCAN_CSO and @CellCAN_SKM
This is what concludes the third Strategic Forum, Cell and Gene Revolution : All hands on deck! From the entire team at CellCAN, thanks to all sponsors, exhibitors, speakers, chairs and delegates for your support and attendance! #CGT#strategicforum2022#CellCAN
The Strategic Forum is the result of strong collaboration of CellCAN with its partners. Special thanks to all who supported this 3rd edition of the Strategic Forum! #CGT#strategicforum2022#CellCAN
An enlightening keynote by Mark Lievonen, Co-Chair for Canada's COVID-19 Vaccine Task Force, about the lessons for future vaccine and therapeutics manufacturing. #CGT#strategicforum2022#CellCAN
Quality networking remain one of the main goals of the forum. Don’t miss tonight’s Networking event, sponsored by CATTI.
#CGT#CellCAN#strategicforum2022"
Solving the talent development crisis for CGT manufacturing is at the heart of this third Strategic Forum. Training at all levels is part of the solution, wether it is internships, e-learning, on-site or executive training.
#CGT#strategicforum2022#CellCAN
Great to be back in person sponsoring the @CellCAN_Network 2022 Strategic Forum! Looking forward to two days of discussion and networking focused on cell and gene therapy. #CellCan#strategicforum2022
Before moving on with our afternoon program, we would like to acknowledge our platinum partners, @CCRM_ca and @C3i_Montreal The 3rd edition of the Strategic Forum is made possible, thanks to your continued commitment and support!
#CGT#strategicforum2022#CellCAN
The Honourable François-Philippe Champagne, Member of Parliament for Saint‑Maurice‒Champlain and Minister of Innovation, Science and Industry, addressed the plenary this morning.
👉 https://t.co/UzFhKJiNSN
#CGT#strategicforum2022#CellCAN
50% of CGT's fail due to insufficient capabilities at the manufacturing stage. #CellCAN is proud to partner with CATTI to address critical capabilities such as personnel training for biomanufacturing and aiding the success of innovative therapeutics!
#CGT#strategicforum2022
Facts from this morning's talk: 2021 saw historical record-breaking investments in CGT's across the globe. This is evidence for the need to strategize now more than ever to work together in making the most of this upcoming revolution!
#CGT#strategicforum2022#CellCAN
$10.5M contribution from NGen Canada to a $34.8M project to support commercial scale manufacturing of cell therapies with @MorphocellTech, @OmniaBio, @ExcellThera, @aspectbiosys and @CATTI_Training. Together to advance #CGT in Canada https://t.co/bZtmjPxKjb
It's the launch of the main conference! Two days of discussion, networking and conferences revolving around Cell & Gene Therapy. From manufacturing to investment and training: All hands on deck! #CGT#CellCAN#strategicforum2022